Your browser is no longer supported. Please, upgrade your browser.
TLOG TetraLogic Pharmaceuticals Corporation weekly Stock Chart
TLOG [NASD]
TetraLogic Pharmaceuticals Corporation
Index- P/E- EPS (ttm)-1.75 Insider Own35.72% Shs Outstand27.14M Perf Week-23.53%
Market Cap1.76M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.57M Perf Month27.45%
Income-43.00M PEG- EPS next Q- Inst Own18.00% Short Float6.04% Perf Quarter-58.33%
Sales- P/S- EPS this Y-30.10% Inst Trans-15.59% Short Ratio2.00 Perf Half Y-79.88%
Book/sh-0.90 P/B- EPS next Y- ROA-64.70% Target Price1.00 Perf Year-77.59%
Cash/sh0.32 P/C0.20 EPS next 5Y- ROE461.40% 52W Range0.03 - 0.62 Perf YTD6.12%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-89.44% Beta-
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin- 52W Low118.33% ATR0.02
Employees29 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)49.50 Volatility31.59% 53.41%
OptionableNo Debt/Eq- EPS Q/Q46.50% Profit Margin- Rel Volume0.09 Prev Close0.06
ShortableYes LT Debt/Eq- EarningsNov 10 Payout- Avg Volume591.64K Price0.07
Recom2.00 SMA203.06% SMA502.15% SMA200-66.53% Volume3,660 Change0.77%
Jan-07-16Reiterated ROTH Capital Buy $5 → $1
Dec-31-15Initiated ROTH Capital Buy $5
May-07-15Reiterated Needham Buy $10 → $7
Mar-02-15Reiterated Needham Buy $16 → $10
Apr-09-14Upgrade WBB Securities Speculative Buy → Buy $12 → $15.50
Mar-10-14Initiated WBB Securities Speculative Buy $12
Dec-30-16 08:25AM  TetraLogic completes $12M asset sale to Swedish drug developer at bizjournals.com -46.74%
Dec-29-16 10:30AM  TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB GlobeNewswire +268.00%
Nov-22-16 08:27AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to
Nov-15-16 01:04PM  TETRALOGIC PHARMACEUTICALS CORP Financials
Nov-14-16 05:07PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements +11.11%
Nov-04-16 12:20PM  $12M deal: Malvern biopharm firm sells assets to Swedish drug developer at bizjournals.com -44.55%
Nov-03-16 05:29PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Costs Associated with -12.00%
Nov-02-16 04:30PM  TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock GlobeNewswire -10.71%
Oct-19-16 04:07PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Sep-06-16 04:06PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Sep-01-16 04:03PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Aug-11-16 01:24PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Jul-22-16 04:19PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers -22.47%
Jul-20-16 04:21PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Jul-18-16 09:48AM  Coverage Initiated on Select Biotech Stocks
Jun-15-16 04:06PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-04-16 01:32PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Apr-26-16 08:26AM  4 Trending Small Cap Stocks That You Need To Watch Today Accesswire -28.16%
Apr-25-16 12:44PM  Penny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25 Accesswire +66.10%
Apr-15-16 12:09PM  Top Penny Stocks: Four Small Cap Stocks You Should Be Watching On April 15th Accesswire
Apr-07-16 04:07PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-16-16 03:31PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report -9.52%
Feb-26-16 07:01AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Feb-03-16 01:49PM  These Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016 Accesswire
12:37PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-29-16 06:04AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Regulation FD Disclosure
Jan-25-16 10:04AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul
Jan-22-16 08:11AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Dire
Jan-13-16 09:45AM  Insider Alert: Here's Why These Small Caps Could Be Ready To Bounce Accesswire +6.25%
Jan-07-16 08:41AM  Here's Why Tetralogic Pharmaceuticals Is Down 70% -76.06%
Jan-06-16 04:11PM  TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs GlobeNewswire -7.61%
Dec-31-15 10:02AM  LifeSci Capital Initiates Coverage of TetraLogic Pharmaceuticals Corporation Accesswire +21.83%
08:30AM  Roth Capital's New Buy Rating On TetraLogic: 'SMAC'ing Cancer Around'
06:23AM  Coverage initiated on TetraLogic Pharmaceuticals by ROTH Capital
Dec-09-15 09:38AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Nov-09-15 07:00AM  TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hematology Annual Meeting GlobeNewswire
Nov-06-15 09:52AM  Odey Asset Management and Clinton Group Discarding Two Low-Priced Stocks, While Whitebox Advisors Goes Long This Biotech at Insider Monkey
Nov-04-15 04:01PM  TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update GlobeNewswire
01:05PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Nov-02-15 07:00AM  TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata GlobeNewswire
Oct-07-15 08:14AM  Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market Accesswire
Sep-28-15 02:33PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.50%
Aug-25-15 06:02AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
Aug-05-15 04:01PM  TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update GlobeNewswire -7.75%
01:37PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
06:44AM  *** DATA NOT AVAILABLE *** at noodls
Jul-29-15 07:31AM  TetraLogic to Present at the Jefferies 2015 Hepatitis B Summit GlobeNewswire
Jul-20-15 04:02PM  TetraLogic Provides Update on Hepatitis B Clinical Program GlobeNewswire
Jul-18-15 09:10AM  Insider Buying Slow but Sure as Earnings Results Pour In at 24/7 Wall St.
Jul-09-15 02:13PM  4 Stocks Under $10 Making Big Moves at TheStreet
Jul-01-15 11:51AM  Huge Gainers: Zogenix, Inc. (ZGNX), Tetralogic Pharmaceuticals Corp, WPCS International Incorporated (WPCS) and More at Insider Monkey
10:36AM  Mid-Morning Market Update: Markets Open Higher; Constellation Brands Q1 Profit Tops Views
Jun-30-15 05:21PM  Tetralogic, Freeport-McMoRan, Melco Crown Lead Tuesday's After-Hours Movers
04:01PM  TetraLogic Announces Update on MDS Clinical Program GlobeNewswire
Jun-04-15 04:34PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-14-15 01:44PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
May-06-15 02:24PM  TetraLogic Announces Termination of Public Offering at noodls -36.51%
12:52PM  TetraLogic Announces Termination of Public Offering GlobeNewswire
12:04PM  TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial at noodls
12:04PM  PDF Add to Briefcase File is in Briefcase at noodls
11:15AM  Malvern biopharm company's stock plunges after study is stopped at bizjournals.com
10:14AM  TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial GlobeNewswire
May-01-15 01:33PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements -10.34%
09:55AM  TetraLogic Announces Pricing of $25 Million Public Offering at noodls
09:55AM  PDF Add to Briefcase File is in Briefcase at noodls
08:56AM  TetraLogic Announces Pricing of $25 Million Public Offering GlobeNewswire
Apr-30-15 05:07PM  TetraLogic Announces Public Offering of Common Stock at noodls
05:07PM  PDF Add to Briefcase File is in Briefcase at noodls
04:01PM  TetraLogic Announces Public Offering of Common Stock GlobeNewswire
03:57PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disc
Apr-22-15 06:13PM  Nasdaq stocks posting largest volume increases
Apr-21-15 08:28AM  TetraLogic Announces Publication of Two Papers Describing Birinapant's Preclinical Activity in Chronic Hepatitis B at noodls +5.36%
08:28AM  PDF Add to Briefcase File is in Briefcase at noodls
08:00AM  TetraLogic Announces Publication of Two Papers Describing Birinapant's Preclinical Activity in Chronic Hepatitis B GlobeNewswire
Apr-20-15 12:45PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Other Events +14.22%
08:28AM  TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination with KEYTRUDA┬« (pembrolizumab) in Solid Tumors at noodls
08:28AM  TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid Tumors at noodls
08:28AM  PDF Add to Briefcase File is in Briefcase at noodls
08:00AM  TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid Tumors GlobeNewswire
Apr-09-15 10:56AM  TetraLogic to Present at the 14th Annual Needham Healthcare Conference at noodls
10:56AM  PDF Add to Briefcase File is in Briefcase at noodls
10:11AM  TetraLogic to Present at the 14th Annual Needham Healthcare Conference GlobeNewswire
Mar-23-15 05:02PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-13-15 05:21PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements -8.39%
Mar-03-15 05:27PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Feb-27-15 12:57PM  PDF Add to Briefcase File is in Briefcase at noodls
Feb-26-15 04:51PM  TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update at noodls
04:10PM  TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update GlobeNewswire
11:48AM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report
Jan-27-15 06:09PM  Nasdaq stocks posting largest percentage decreases AP
Dec-18-14 07:34AM  PDF Add to Briefcase File is in Briefcase at noodls
07:09AM  TetraLogic Announces Initiation of a Randomized Phase 2 Clinical Trial of SHAPE in Subjects With Cutaneous T-Cell Lymphoma at noodls
07:00AM  TetraLogic Announces Initiation of a Randomized Phase 2 Clinical Trial of SHAPE in Subjects With Cutaneous T-Cell Lymphoma GlobeNewswire
Dec-16-14 07:00AM  TetraLogic Provides Update on Ovarian Cancer Study GlobeNewswire
Dec-04-14 07:30AM  TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 56th Annual American Society of Hematology Annual Meeting GlobeNewswire
Dec-02-14 07:30AM  TetraLogic to Participate in Two Conferences in December GlobeNewswire
Nov-10-14 03:48PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements a EDGAR Online
08:00AM  TetraLogic Pharmaceuticals Announces Results of Preclinical Studies in Hepatitis B GlobeNewswire
Nov-07-14 11:10AM  TetraLogic Pharmaceuticals Announces Appointment of Mary Ann Gray, Ph.D. and Mr. Michael D. Kishbauch as New Directors GlobeNewswire
Nov-05-14 04:41PM  TETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen EDGAR Online
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Clarus Lifesciences II, L.P.10% OwnerFeb 09Sale0.16230,50736,8812,214,523Feb 10 02:33 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 08Sale0.19103,12319,5932,445,030Feb 10 02:33 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 05Sale0.20832,881166,5762,548,153Feb 05 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 04Sale0.14500,02670,0043,381,034Feb 05 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 03Sale0.1582,58312,3873,881,060Feb 05 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 02Sale0.17176,30629,9723,963,643Feb 02 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 01Sale0.20140,00028,0004,139,949Feb 02 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerJan 29Sale0.2652,82613,7354,279,949Feb 02 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerJan 28Sale0.2632,5218,4554,332,775Jan 28 05:07 PM
Clarus Lifesciences II, L.P.10% OwnerJan 27Sale0.27209,98456,6964,365,296Jan 28 05:07 PM
Clarus Lifesciences II, L.P.10% OwnerJan 26Sale0.3069,42520,8284,575,280Jan 28 05:07 PM